Model
Edge
Seres Therapeutics
0001767321
Filing Type
4
Filing Date
2/18/2025
Updated
2/19/25, 6:10 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership